Moreover, the stigma surrounding obesity disproportionately affects lower-income individuals, who are often blamed for their ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Gallstones and Digestive Issues: Losing weight too quickly can increase the risk of gallstones, which can be extremely painful. Additionally, crash dieting can lead to digestive issues such as ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

Research on the gut microbiome has triggered a 'revolution' in nutritional science, and in the last few years, dietary fiber ...

Daniel Mitchell-Jones, co-founder of modelling agency Chapter Management, said: "Yes, things have shifted. In 2020 and 2021, we saw so much more diversity and inclusion on the runways - but body-wise, ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Ozempic and Wegovy has been prescribed to Yorkshire patients hundreds of times in the past year - and it's not for weightloss ...

Even really skinny people like to be on Ozempic, especially these people in Hollywood because they don’t get hungry,” says one plastic surgeon.

is redefining body contouring for individuals who have achieved significant weight loss through medications like Ozempic or other weight loss drugs. Recognizing the unique challenges faced by ...